The EU’s medicines regulator said Wednesday that blood clots should be listed as a rare side effect of the AstraZeneca jab, but the benefits continue to outweigh the risks, as several countries battle fresh virus surges amid vaccine shortfalls. A number of nations have suspended the use of AstraZeneca’s vaccine for younger populations after it […]

The post EU regulator says AZ clot risk ‘very rare’ appeared first on Asia Times.